Avadel Pharmaceuticals plc - American Depositary Shares each re — Cash Flow (NASDAQ:AVDL) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -48.73 M-77.31 M-70.3 M-128.51 M-46.91 M 34.54 M Cash from investing activities -69.72 M56.93 M79.7 M-50.09 M51.78 M 10.54 M Cash from financing activities 179.68 M263 K14.54 M135.34 M15.97 M 5.06 M Free cash flow -48.83 M-77.34 M-71.02 M-128.51 M-46.91 M 34.54 M

Notizie

I risultati di Alkermes in arrivo mentre prende forma la strategia sul sonno

Alkermes earnings up next as sleep strategy takes shape

Harmony Biosciences Makes The Grade (NASDAQ:HRMY)

Obiettivo di prezzo di Alkermes alzato a $47 da $46 da UBS dopo l’accordo con Avadel

Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal

BlackRock rivela una partecipazione del 6,94% in Avadel Pharmaceuticals

BlackRock discloses 6.94% stake in Avadel Pharmaceuticals

TIG Advisors rivela una partecipazione del 4,18% in Avadel Pharmaceuticals

TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals

Goldman Sachs rivela posizione di trading in Avadel Pharmaceuticals

Goldman Sachs discloses trading position in Avadel Pharmaceuticals

Janus Henderson rivela una partecipazione dell’1,87% in Avadel Pharmaceuticals